1. Spivak JL, Barnes DC, Fuchs E, Quinn TC. Serum immunoreactive erythropoietin in HIV-infected patients. JAMA 1989;261:3104–7.
2. Cheong I, Flegg PJ, Brettle RP, Welsby PD, Burns SM, Dhillon B, Leen CL, Gray JA. Cytomegalovirus disease in AIDS: the Edinburgh experience. Int J STD AIDS 1992;3:324–328
3. Snoeck R, Lagneaux L, Delforge A et al. Inhibitory effects of potent inhibitors of human immunodeficiency virus and cytomegalovirus on the growth of human granulocyte-macrophage progenitor cells in vitro. Eur J Clin Microbiol Infect Dis 1990;9:615–619
4. Kravcik S, Toye BW, Fyke K et al. Impact of Mycobacterium avium complex prophylaxis on the incidence of mycobacterial infections and transfusion-requiring anemia in an HIV-positive population. J Acquir Immune Defic Syndr Hum Retroviral 1996;13:27–32
5. Boelaert JR, Weinberg GA, Weinberg ED. Altered iron metabolism in HIV infection: mechanisms, possible consequences, and proposals for management. Infect Agents Dis 1996;5:36–46